Skip to content

Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya

Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya (CoBAnK): A Type III Hybrid Effectiveness-implementation Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06142825
Acronym
CoBAnK
Enrollment
9
Registered
2023-11-22
Start date
2025-03-11
Completion date
2026-06-11
Last updated
2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Transfusion

Brief summary

The strategy of the CoBAnK study is to establish and enable the function of Community-Facility Transfusion Committees (CFTCs) incorporating diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care.

Detailed description

The strategy of the CoBAnK study is to establish and enable the function of Community-Facility Transfusion Committees (CFTCs) incorporating diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care. The CFTC strategy will be evaluated across nine transfusing facilities across three counties in Kenya (two intervention and one control site in each county). While the intervention will be tested in "beta" facilities (i.e., facilities without a co-located blood bank) in each county, blood availability will also be measured in "alpha" facilities (i.e., facilities with co-located blood banks) in the three counties, which supply blood to the beta facilities.

Interventions

OTHERCommunity-Facility Transfusion Committee (CFTC)

Community-Facility Transfusion Committees (CFTCs) are intended to incorporate diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care.

Sponsors

University of Minnesota
Lead SponsorOTHER
Strathmore University
CollaboratorOTHER
University of Pittsburgh
CollaboratorOTHER
Center for Public Health and Development, Kenya (CPHD)
CollaboratorUNKNOWN
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Type III hybrid effectiveness-implementation trial

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Eligibility criteria for study sites (beta hospitals): * Transfusing hospital at level 3 or higher * Has conducted at least 20 blood transfusions in the preceding year * Does not have a KTTA-approved blood bank (regional or satellite) in the facility premises * Receives blood from a blood bank at an Alpha Facility in the same county

Design outcomes

Primary

MeasureTime frameDescription
Met blood needThe time required for the hospital laboratory to process a request for blood for transfusion, up to two weeks.The proportion of transfusion requests resulting in dispatch of blood products from the laboratory

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 19, 2026